XML 11 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Loss and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
EXPENSES    
Research and development $ 7,097 $ 2,799
General and administrative 5,797 3,183
Total operating expenses 12,894 5,982
OTHER INCOME (EXPENSE)    
Interest income 322 368
Interest expense [note 6] (185) (813)
Change in fair value of contingent consideration [note 4 and note 5] (91) (52)
Other expense 21 (15)
Total other income (expense) 67 (512)
Net loss (12,827) (6,494)
OTHER COMPREHENSIVE INCOME    
Net unrealized gain on marketable securities (25)  
Total other comprehensive income (25)  
Comprehensive loss $ (12,852) $ (6,494)
Basic net loss per common share [note 7[d]] $ (0.37) $ (0.26)
Diluted net loss per common share [note 7[d]] $ (0.37) $ (0.26)
Weighted average shares used in computation of basic net loss per common share [note 7[d]] 34,685,072 25,048,134
Weighted average shares used in computation of diluted net loss per common share [note 7[d]] 34,685,072 25,048,134